Opportunity
SAM #6912710440008
Award for Novartis Pluvicto and Lutathera cancer-treatment radiopharmaceuticals
Buyer
VA 262 Network Contract Office 22
Posted
October 29, 2026
Identifier
6912710440008
NAICS
325412, 424210
The Department of Veterans Affairs awarded a one-month bridge order for cancer-treatment radiopharmaceuticals for VA Greater Los Angeles Healthcare System. - Government buyer: Department of Veterans Affairs, VA Greater Los Angeles Healthcare System, Network Contracting Office 22. - Awarded vendor and OEM: Novartis Pharmaceuticals Corporation, the named manufacturer and source of the requested medicines. - Products: Pluvicto and Lutathera radiopharmaceuticals. Quantities and part numbers are not specified. - Purpose and requirements: Maintain continuity of cancer care while the longer-term order is finalized. The justification cites urgent patient-care needs, the specialized and proprietary nature of the medicines, and Novartis as the only authorized source listed in the VA NAC catalog. - Award amount: $769,496.80. - Period of performance: Projected one-month bridge period; specific calendar dates are not included here.